Sonoma Pharmaceuticals Inc
Research Sonoma Pharmaceuticals Inc (SNOA) on Bullrun: market cap USD 6.46M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSNOA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 6.46M
- Financial periodQ2 2026
- RevenueUSD 6.41M
- Net income-USD 330.00K
- Free cash flow-USD 651.00K
- Gross margin40.2%
Valuation Snapshot
latest market cap is USD 6.46M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 14.29M | -USD 3.46M | -USD 168.00K | 38.2% | -2.79 | USD 5.37M | USD 220.00K | USD 4.41M |
| FY2024 | USD 12.74M | -USD 4.84M | -USD 2.40M | 37.3% | -10.63 | USD 3.13M | USD 323.00K | USD 6.14M |
| FY2023 | USD 13.27M | -USD 5.15M | -USD 6.42M | 33.7% | -1.52 | USD 3.82M | USD 431.00K | USD 7.98M |
| FY2022 | USD 12.63M | -USD 5.09M | -USD 4.39M | 31.6% | -1.92 | USD 7.40M | USD 0 | USD 8.70M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 6.46M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 6.30M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 4.35M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.46M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 3.48M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 14.14M | n/a | n/a | n/a |
About Sonoma Pharmaceuticals Inc
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Sonoma Pharmaceuticals Inc's market cap?
Sonoma Pharmaceuticals Inc's market capitalization is USD 6.46M.
What does Sonoma Pharmaceuticals Inc do?
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.